简体中文 | 繁體中文 | English

Products & Services News

2018-12-05 09:56 ABB enables groundbreaking trial of remotely operated passenger ferry
2018-12-05 09:54 Mopria Alliance Launches Mopria Scan App and Universal Standard
2018-12-05 09:51 MulteFire Alliance Completes Its IoT Optimized Specification
2018-12-04 16:46 Takeda to Present Positive Data from TOURMALINE-MM3, First Pivotal Phase 3 Placebo Controlled Trial Evaluating Proteasome Inhibitor Treatment in Maintenance Setting
2018-12-04 16:45 Värde Partners Closes First Dedicated Asia Credit Fund
2018-12-04 16:08 Tiziana Completes Patient Enrollment in a Phase 2a Trial to Evaluate Tolerability and Anti-Tumor Activity of Milciclib in Hepatocellular Carcinoma (HCC)
2018-12-04 10:30 C3Nano Announces the Opening of its First Mass Production Factory in China
2018-12-04 10:23 A CMI Solar Receiver Will Equip the World's Tallest Solar Tower in Dubai
2018-12-04 09:56 Argon Design Licenses Argon Streams AV1 to Realtek Semiconductor
2018-12-04 09:54 Celgene Corporation Announces Initial Clinical Data from Ongoing Phase 1/2 Evolve Trial with Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma at ASH 2018
2018-12-04 09:52 Kyriba Continues to Expand its #1 Global Solutions Ecosystem with New WorldFirst Partnership
2018-12-04 09:50 Vitruvias Therapeutics Inc., and Sunny Pharmtech Inc., Announce the FDA Approval of Generic Aminocaproic Acid 500 mg and 1000 mg Tablets
2018-12-03 16:05 FPT Television Selects Telaria to Manage and Monetize Connected TV Inventory Programmatically
2018-12-03 15:02 Idemitsu Kosan: Construction of an OLED Materials Plant in China
2018-12-03 14:56 MIRAI DINING Co., Ltd.: KYOTO MISO RAMEN KAZU to Open on December 1st, 2018
2018-12-03 10:35 2Easy: a Hong Kong Startup is Targeting to Launch a Few More Asian Nations
2018-12-03 10:31 Tokyo Gas Switches to Rimini Street Support for SAP Applications
2018-12-03 10:26 Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 MEDALIST Trial Evaluating Luspatercept in Patients with Myelodysplastic Syndromes at the ASH 2018 Plenary Session
2018-12-03 10:22 Celgene Corporation Announces Initial Phase 1/2 Liso-cel Data in Patients with Relapsed/Refractory CLL, Including Those with High-Risk Disease, Previously Treated with Ibrutinib, at ASH 2018
2018-12-03 10:19 Splunk Announces Integrations With New Amazon Web Services Security Hub

Business Wire Weibo

Press Releases

Latest Releases